ASPEN PHAR.UN.ADR /1 O.N. Capital Reinvestment Ratio
ASPEN PHAR.UN.ADR /1 O.N. capital reinvestment ratio. ASPEN PHAR.UN.ADR /1 O.N. (LDZU) has a Capital Reinvestment Ratio of 0.98x as of June 2025, meaning it reinvests 1% of its operating cash flow (€5.16 Billion) in capital expenditures (€5.05 Billion). See how much free cash does ASPEN PHAR.UN.ADR /1 O.N. generate to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of ASPEN PHAR.UN.ADR /1 O.N. (2022–2025)
Capital reinvestment ratio of ASPEN PHAR.UN.ADR /1 O.N. from 2022 to 2025. This chart tracks ASPEN PHAR.UN.ADR /1 O.N.'s Capital Reinvestment Ratio across 4 annual periods. See LDZU FCF to total liabilities ratio to measure the company's free cash flow as a share of total liabilities.
ASPEN PHAR.UN.ADR /1 O.N. Capital Reinvestment Ratio by Year (2022–2025)
ASPEN PHAR.UN.ADR /1 O.N. capital reinvestment ratio by year from 2022 to 2025. For the full cash flow conversion analysis, see LDZU cash flow conversion.
| Year | Reinvestment Ratio | Operating CF (EUR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.98x | €5.16 Billion | €5.05 Billion | ▲ +10.2% |
| 2024 | 0.89x | €6.22 Billion | €5.54 Billion | ▲ +54.3% |
| 2023 | 0.58x | €5.52 Billion | €3.18 Billion | ▲ +14.8% |
| 2022 | 0.50x | €5.37 Billion | €2.70 Billion | — |